Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Ophthalmology and Therapy- United Kingdom

doi 10.1007/s40123-016-0075-1

Full Text

Abstract

Available in

Categories

Ophthalmology

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Macular Atrophy in Neovascular Age Related Macular Degeneration

Journal of Clinical Review & Case Reports
2019English

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews
2016Norwegian Bokmål

Role of Interleukin 33 in Neovascular Age-Related Macular Degeneration

The Lancet
Medicine
2016English

Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2017English

Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine
Medicine
2006English

Mineralocorticoid Receptor Antagonism Limits Experimental Choroidal Neovascularization and Structural Changes Associated With Neovascular Age-Related Macular Degeneration

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Neovascular Age-Related Macular Degeneration Is Associated With Cataract Surgery

Acta Ophthalmologica
MedicineOphthalmology
2017English

Treatment of Age-Related Neovascular Macular Degeneration: The Patient’s Perspective

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Patient Preferences in the Treatment of Neovascular Age-Related Macular Degeneration

Ophthalmology
Ophthalmology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy